OTTAWA, Sept. 1 (Xinhua) -- Health Canada on Thursday authorized an adapted version of the Moderna Spikevax COVID-19 vaccine which targets the original SARS-CoV-2 virus from 2019 and the Omicron (BA.1) variant.
According to a statement issued by the agency, this vaccine, known as a "bivalent" vaccine, is authorized for use as a booster dose in individuals 18 years of age or older.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
